Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

37.69
Delayed Data
As of Dec 06
 +0.02 / +0.05%
Today’s Change
37.36
Today|||52-Week Range
45.58
-5.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line7.6B8.8B4.7B12.8B
 
 
 
 
 
Depreciation2.3B2.2B2.4B2.5B
 
 
 
 
 
Total Other Cash Flow-4.8B-1.1B-722.8M-14.9B
 
 
 
 
 
Funds From Operations5.0B9.9B6.4B360.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-799.6M-346.1M-1.1B-2.6B
 
 
 
 
 
Net Cash Flow - Operating Activities5.8B10.3B7.5B2.9B
 
 
 
 
 
 
InvestingIncrease In Investments-522.4M-220.8M-151.5M-152.5M
 
 
 
 
 
Decrease In Investments401.4M787.8M340.8M1.4B
 
 
 
 
 
Capital Expenditures-1.7B-1.9B-2.0B-2.1B
 
 
 
 
 
Fixed Asset Disposal108.3M3.0B434.7M15.7B
 
 
 
 
 
Net Assets From Acquisitions -3.6B-1.3B-1.3B-5.4B
 
 
 
 
 
Other Investing - Sources1.7B213.0M543.3M360.0M
 
 
 
 
 
Net Cash Flow Investing-4.3B-220.8M-3.0B9.0B
 
 
 
 
 
 
FinancingShort Term Borrowings-1.3B-2.9B-2.8B-3.6B
 
 
 
 
 
Long Term Borrowings7.1B3.0B3.2B0.00
 
 
 
 
Long Term Debt Reduction-55.7M-48.6M-37.9M-38.1M
 
 
 
 
 
Net Proceeds Stock Sale659.4M916.2M275.0M111.3M
 
 
 
 
 
Common Preferred Redeemed-4.0B-2.4B-548.3M-151.0M
 
 
 
 
 
Common Dividends-6.1B-5.8B-6.3B-5.9B
 
 
 
 
 
Cash Dividends Paid - Total-6.1B-5.8B-6.3B-5.9B
 
 
 
 
 
Other Sources - Financing0.000.000.00355.4M
 
 
Other Uses - Financing329.7M473.0M358.9M361.5M
 
 
 
 
 
Net Cash Flow - Financing-4.1B-7.7B-6.6B-9.6B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-146.5M-231.8M138.3M-68.6M
 
 
 
 
 
 
Net Change In Cash-2.6B2.3B-2.1B2.3B